Real-time enrollment status for this refractory acute myeloid leukemia (aml) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 8:45 PM UTC
| NCT Number | NCT07347418 |
| Recruiting Status | Recruiting |
| Condition | Refractory Acute Myeloid Leukemia (AML) |
| Phase | PHASE1 |
| Target Enrollment | 23 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Colorado, Denver |
| Last Updated on CT.gov | June 29, 2026 (Jun 29, 2026) |
As of August 29, 2026: Clinical trial NCT07347418 is currently recruiting participants. This phase1 study for refractory acute myeloid leukemia (aml) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Colorado, Denver. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07347418 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07347418 was last updated Jun 29, 2026 (June 29, 2026). HelloStudys verifies this status automatically.